Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 2.

Journal Article

Dietrich, Sascha, Pircher, Andreas ORCID: 0000-0002-7747-3012, Endris, Volker, Peyrade, Frederic, Wendtner, Clemens-Martin, Follows, George A., Huellein, Jennifer, Jethwa, Alexander ORCID: 0000-0003-3869-8662, Ellert, Elena, Walther, Tatjana, Liu, Xiyang, Dyer, Martin J. S., Elter, Thomas, Brummer, Tilman ORCID: 0000-0003-4387-7905, Zeiser, Robert, Hermann, Michael, Herold, Michael, Weichert, Wilko, Dearden, Claire, Haferlach, Torsten, Seiffert, Martina ORCID: 0000-0001-5155-663X, Hallek, Michael, von Kalle, Christof, Ho, Anthony D., Gaehler, Anita, Andrulis, Mindaugas, Steurer, Michael and Zenz, Thorsten (2016). BRAF inhibition in hairy cell leukemia with low-dose vemurafenib. Blood, 127 (23). S. 2847 - 2856. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020

Salwender, Hans, Bertsch, Uta, Weisel, Katja, Duerig, Jan, Kunz, Christina, Benner, Axel, Blau, Igor W., Raab, Marc Steffen, Hillengass, Jens, Hose, Dirk, Huhn, Stefanie, Hundemer, Michael, Andrulis, Mindaugas, Jauch, Anna, Seidel-Glaetzer, Andrea, Lindemann, Hans-Walter, Hensel, Manfred, Fronhoffs, Stefan, Martens, Uwe, Hansen, Timon, Wattad, Mohammed, Graeven, Ullrich, Munder, Markus, Fenk, Roland, Haenel, Mathias, Scheid, Christof and Goldschmidt, Hartmut (2019). Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma. BMC Cancer, 19. LONDON: BMC. ISSN 1471-2407

This list was generated on Sun Jan 24 04:22:58 2021 CET.